GASTROINTESTINAL MANIFESTATIONS AND EPIDEMIOLOGICAL FEATURES IN COVID-19 PATIENTS

This study explores the prevalence and characteristics of gastrointestinal (GI) symptoms in patients infected with COVID-19. A considerable proportion of patients experienced GI disturbances such as loss of appetite, nausea, diarrhea, and vomiting. Early recognition of these symptoms is crucial for timely diagnosis, effective management, and controlling the spread of the virus. The study also emphasizes the importance of comprehensive preventive strategies, including hygiene, household monitoring, and public awareness.